Maintenance of CD8+ T-cell memory following infection with recombinant sindbis and vaccinia viruses

Virology

Volumn 270, Issue 1, 2000, Pages 54-64

  Villacres, Maria C ^a   Zuo, Jun ^a   Bergmann, Cornelia C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINDBIS VIRUS; SPLEEN CELL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION; VIRUS RECOMBINANT;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; SINDBIS VIRUS; TRIXIS; VACCINIA; VACCINIA VIRUS;

EID: 0034712975     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0255     Document Type: Article

References (60)

1. Ahmed R., Gray D. Immunological memory and protective immunity: Understanding their relation. Science. 272:1996;54-60.
2. Altman J. D., Moss P. A. H., Goulder P. J. R., Barouch D. H., McHeyzer-Williams M. G., Bell J. I., McMichael A. J., Davis M. M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
3. Bergmann C., Stohlman S., McMillan M. An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV-1 envelope glycoprotein. Eur. J. Immunol. 23:1993;2777-2781.
4. + T cells during viral persistence in the CNS. J. Immunol. 163:1999;3379-3387.
5. Bergmann C. C., Tong L., Cua R., Sensintaffer J., Stohlman S. Cytotoxic T cell repertoire selection: A single amino acid determines alternate class I restriction. J. Immunol. 152:1994;5603-5612.
6. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. J. Immunol. 146:1991;4301-4307.
7. Buller R. M., Palumbo G. J. Poxvirus pathogenesis. Microbiol. Rev. 55:1991;80-122.
8. Busch D. H., Philip I. M., Vijh S., Pamer E. G. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity. 8:1998;353-362.
9. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1998;1395-1402.
10. Carter L. L., Dutton R. W. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J. Immunol. 155:1995;1028-1031.
11. Combadiere B., Reise Sousa C., Trageser C., Zheng L.-X., Kim C. R., Lenardo M. J. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. Immunity. 9:1998;305-313.
12. Croft M., Carter L., Swain S. L., Dutton R. W. Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J. Exp. Med. 180:1994;1715-1728.
13. Davis N. L., Brown K. W., Johnston R. E. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Virol. 70:1996;3781-3787.
14. Demkowicz W. E. Jr., Littaua R. A., Wang J., Ennis F. A. Human cytotoxic T-cell memory: Long-lived responses to vaccinia virus. J. Virol. 70:1996;2627-2631.
15. Driver D. A., Polo J. M., Beli B. A., Banks T. A., Hariharan M., Dubensky T. W. Jr. Plasmid DNA-based alphavirus expression vectors for nucleic acid immunization. Curr. Res. Mol. Ther. 1:1998;510-517.
16. Dubensky T. W. Jr., Driver D. A., Polo J. M., Belli B. A., Latham E. M., Ibanez C. E., Chada S., Brumm D., Banks T. A., Mento S. J., Jolly D. J., Chang S. M. W. Sindbis virus DNA-based expression vectors: Utility for in vitro and in vivo gene transfer. J. Virol. 70:1996;508-519.
17. Erard F., Wild M. T., Garcia-Sanz J. A., Le Gros G. Switch of CD8 T cells to noncytolytic CD8-, CD4-cells that make Th2 cytokines and help B cells. Science. 260:1993;1802-1805.
18. Ferrari G., Humphrey W., McElrath M. J., Excler J. L., Duliege A. M., Clements M. L., Corey L. C., Bolognesi D. P., Weinhold K. J. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. Natl. Acad. Sci. USA. 94:1997;1396-1401.
19. Fleury B., Janvier G., Pialoux G., Buseyne F., Robertson M. N., Tartaglia J., Paoletti E., Kieny M. P., Excler J. L., Riviere Y. Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160. J. Infect. Dis. 174:1996;734-738.
20. + T cells in primary and secondary influenza pneumonia. Immunity. 8:1998;683-691.
21. Frolov I., Hoffman T. A., Pragal B. M., Dryga S. A., Huang H. V., Schlesinger S., Rice C. M. Alphavirus-based expression vectors: Strategies and applications. Proc. Natl. Acad. Sci. USA. 93:1996;11371-11377.
22. Griffin D., Levine B., Tyor W., Ubol S., Despres P. The role of antibody in recovery from alphavirus encephalitis. Immunol. Rev. 159:1997;155-161.
23. Hahn C. S., Hahn Y. S., Braciale T. J., Rice C. M. Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc. Natl. Acad. Sci. USA. 89:1992;2679-2683.
24. + immune T cells. J. Virol. 65:1991;220-224.
25. + CTL response to HSV in C57BL/6 mice. Cell. Immunol. 133:1991;234-252.
26. + T cell depletion in simian immunodeficiency virus-infected macques. J. Exp. Med. 189:1999;991-998.
27. Johnson R. P., Glickman R. L., Yang J. Q., Kaur A., Dion J. T., Mulligan M. J., Desrosiers R. C. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. J. Virol. 71:1997;7711-7718.
28. Johnson R. P., Lifson J. D., Czajak S. C., Cole K. S., Manson K. H., Glickman R. L., Yang J. Q., Montefiori D. C., Montelaro R., Wyand M. S., Desrosiers R. C. Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: Inverse relationship of degree of protection with level of attenuation. J. Virol. 73:1999;4952-4961.
29. Kalams S. A., Walker B. D. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 188:1998;2199-2204.
30. Karupiah G., Coupar B. E. H., Andrew M. E., Boyle D. B., Phillips S. M., Müllbacher A., Blanden R. V., Ramshaw I. A. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J. Immunol. 144:1990;290-298.
31. Koszinowski U. H., Reddehase M. J., Jonjic S. The role of CD4 and CD8 T cells in viral infections. Curr. Opin. Immunol. 3:1991;471-475.
32. Lenardo M., Chan F. K.-M., Hornung F., McFarland H., Siegel R., Wang J., Zheng L. Mature T lymphocyte apoptosis: Immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:1999;221-253.
33. Levine B., Hardwick J. M., Trapp B. D., Crawford T. O., Bollinger R. C., Griffin D. E. Antibody-mediated clearance of alphavirus infection from neurons. Science. 254:1991;856-860.
34. Li L., Sad S., Kagi D., Mosmann T. R. CD8 Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions. J. Immunol. 158:1997;4152-4161.
35. Linn M. L., Mateo L., Gardner J., Suhrbier A. Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J. Virol. 72:1998;5146-5153.
36. Lustig S., Jackson A. C., Hahn C. S., Griffin D. E., Strauss E. G., Strauss J. H. Molecular basis of Sindbis Virus neurovirulence in mice. J. Virol. 62:1998;2329-2336.
37. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:1994;8056-8063.
38. McMichael A. Preparing for HIV vaccines that induce cytotoxic T lymphocytes. Curr. Opin. Immunol. 10:1998;379-381.
39. + T cells using an ELISPOT assay. J. Immunol. Methods. 181:1995;45-54.
40. k. Immunogenetics. 7:1978;551-561.
41. Murali-Krishna K., Altman J. D., Suresh M., Sourdive D., Zajac A., Miller J., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
42. + T cell responses induced by recombinant influenza and vaccinia viruses. Cell. Immunol. 173:1996;96-107.
43. Oehen S., Brduscha-Riem K. Differentiation of naïve CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J. Immunol. 161:1998;5338-5346.
44. Pugachev K. V., Mason P. W., Shope R. E., Frey T. K. Double subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Virology. 212:1995;587-594.
45. + T and and B cell epitopes: Comparison of their immunogenicity and capacity to induce protective immunity. J. Immunol. 153:1994;4636-4648.
46. Romero P., Dunbar P. R., Valmori D., Pittet M., Ogg G. S., Rimoldi D., Chen J.-L., Lienard D., Cerottini J.-C., Verundolo V. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1998;1641-1650.
47. + lymphocytes. Science. 283:1999;857-860.
48. Shearer G. M. HIV-induced immunopathogenesis. Immunity. 9:1998;587-593.
49. Slifka M. K., Shen H., Matloubian M., Jensen E. R., Miller J. F., Ahmed R. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. J. Virol. 70:1996;2902-2910.
50. + T cells. J. Immunol. 160:1998;2896-2904.
51. Strauss J. H., Strauss E. G. The alphaviruses: Gene expression, replication, and evolution. Microbiol. Rev. 58:1994;491-562.
52. Takahashi H., Cohen J., Hosmalin A., Cease K. B., Houghten R., Cornette J. L., DeLisi C., Moss B., Germain R. N., Berzofsky J. A. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotien gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 85:1988;3105-3109.
53. Tsuji M., Bergmann C. C., Takita-Sonoda Y., Murata K., Rodrigues E. G., Nussenzweig R. S., Zavala F. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J. Virol. 72:1998;6907-6910.
54. + T-cell memory is induced by Sendai Virus infection of mice. J. Virol. 73:1999;7278-7286.
55. + T cell frequencies from acute infection into long term memory. J. Immunol. 161:1998;367-374.
56. Villacres M. C., Bergmann C. C. Enhanced cytotoxic T cell activity in IL-4-deficient mice. J. Immunol. 162:1999;2663-2670.
57. Wesselingh S. L., Levine B., Fox R. J., Choi S., Griffin D. E. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J. Immunol. 152:1994;1289-1297.
58. Xiong C., Levis R., Shen P., Schlesinger S., Rice C. M., Huang H. V. Sindbis virus: An efficient, broad host range vector for gene expression in animal cells. Science. 243:1989;1188-1191.
59. + cells in human immunodeficiency virus type I pathogenesis: Cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:1997;273-311.
60. Zajac A. J., Blattman J. N., Murali-Krishna K., Sourdive D. J. D., Suresh M., Altman J. D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:1998;2205-2213.